| Tag | Content |
|---|
EnhancerAtlas ID | HS182-20121 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr7:102080400-102082020 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOSL2 | MA0478.1 | chr7:102080792-102080803 | CTGAGTCATCC | - | 6.32 | | HES2 | MA0616.2 | chr7:102081123-102081133 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr7:102081123-102081133 | GGCACGTGCC | - | 6.02 | | JUN(var.2) | MA0489.1 | chr7:102080792-102080806 | CTGAGTCATCCCCT | - | 6.39 | | JUNB | MA0490.1 | chr7:102080792-102080803 | CTGAGTCATCC | - | 6.14 | | Lhx3 | MA0135.1 | chr7:102080536-102080549 | GATTAATTAATTA | - | 7.34 | | POU6F1 | MA0628.1 | chr7:102080537-102080547 | ATTAATTAAT | + | 6.02 | | POU6F1 | MA0628.1 | chr7:102080537-102080547 | ATTAATTAAT | - | 6.02 | | Stat6 | MA0520.1 | chr7:102080586-102080601 | GGTTTCCTGAGAAAA | + | 6.16 |
|
| | Number of super-enhancer constituents: 11 | ID | Coordinate | Tissue/cell |
| SE_10269 | chr7:102081317-102083527 | CD19_Primary | | SE_11022 | chr7:102080216-102088535 | CD20 | | SE_32635 | chr7:102081226-102086421 | GM12878 | | SE_43600 | chr7:102080345-102088157 | MM1S | | SE_53584 | chr7:102080516-102081465 | Spleen | | SE_58603 | chr7:102040407-102092313 | Ly1 | | SE_59253 | chr7:102055636-102092627 | Ly3 | | SE_60478 | chr7:102022497-102092339 | DHL6 | | SE_62031 | chr7:102047957-102092277 | Toledo | | SE_62443 | chr7:102048336-102086597 | Tonsil | | SE_67206 | chr7:102080345-102088157 | MM1S |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH07I102439 | chr7 | 102080080 | 102084282 |
|
Enhancer Sequence | CGCCTGTAAT CCCAGCTACT TGGGAGGCTG AGACACAAGA ATCGCTTGAA CCTGGGAGGC 60
CGGAGGTTGC AGTGAGCCAA GGTCACGCCA CTATACTCCA GCTGGTCAAG AGTGAGACTT 120
TGTCTCGAAA TAAATAGATT AATTAATTAA AAAGATAAAA TCAAATCAAA TCGCTGCATG 180
GTACAGGGTT TCCTGAGAAA AGGCGCCCAT GTCTGCCCCG TCTCAGGCAC CACCCAAAAG 240
TTTGGAACTC TCAGGGATCT CTGAGCAGGG CCTCAGAGAT TGATTGGGGT TGGATCAGTT 300
TAGCCCAGTT AGCGATGCAG ACGTTCCTGG AATCTGGCCT CCAGGGTGAC AAAGGAGAGC 360
TTTTGGCCTG GCTCCCAGCG GCCGCCTTCC TTCTGAGTCA TCCCCTAGGA CAAGAGTCAG 420
TTTCCGACAA AGCTGCGGCT CTGACAAGGG GCCCATCTCC TGTTGACTCC AAAGCCGCTG 480
ACCCACACCC CTGGAGGGAA TTGTCCCAGA GGTTAAGGAC TCACAGTGAG GACACAACAG 540
TATGCTCACA GGTCCTATTG GGTGGAAGTG ATTTATTTGT TTTTTGTTTT GTTTTTAGAG 600
ACAGGGTCCC ACTCTGTTGC CCAGGCTGGA GAGGGCGGTG GTGTGATCAT GGCTCACTGC 660
AGCCTCTACC TCCTGAGCTC AAGCCATCCT CCTGCCTCAG TCTCCTGAGT AGCTGGAATT 720
ATAGGCACGT GCCACCATGC CTGGCTAATT TTTTTTTTCT TTTTTCAGAG ACAAGTTCTC 780
TGCTCTGTTG CCTAGGCTGG AGTGCGGGGG TGCAATCATG GCTCACTGCA GTCTTGAACT 840
CTCAAGTGAT TTTCCCACCT CGGCCTCCCA AAGTGCTAGC ATTGCACCTT GTCCAGCCTG 900
TTTCCTTATG TGAAAACAAT TATTGTTTTT CTTTTTGTTT GTTTTTGTTT TTGTTTTGAG 960
ATGGAGTCTT GCTCTGTCAC CCAGGCTGGA GTGCAGTGGT GTGATTTCAG CTCACTGCAG 1020
CCTCTGCCTC CTGGATTCAA GCGATTCTCC TGCCTCAGCC TTTCGAGTAG CTGGGACTAC 1080
AGGCACACAT CACCACGCCC AGCTAATTTT GATATTCTTA GTAGAGATGG GGTTTCACCA 1140
TGTTGGCCAG GCTGGGCTCG AACTCCTGAC CTCAGGTGAT CCGCCACCCT CGGCCTCCCA 1200
AAGTGCTGGG ATTACAGGCA GGAGCCACCG TGCCCAGCCT CTATTGTTTT TCTGTAGGCC 1260
GGAGCCTCAA TTGTTAGATT GATGGTGCAA TTTAAAAGAA AAAGCTGGCT GGGTGTGGTG 1320
GCTCACGCCT GTAATCCCAG CACTTTGGGA GGCTGAGGTG GGCAGATCAC CTGGTCAGGA 1380
GTTCGAGACC AGCCTGGCCA ACATGGTGAC ACCCCGTCTC TACTAAAAAT ACAAAAATTA 1440
GCTGGACGTG GCGGCAGATG CCTGTAATCC CAGCTACTCC AGAGGCTGAG ACGGAGAATT 1500
GCTTGAACCC GGGAGGCGGA GGTTGCACTG AGCCGAGATT GCATCACTGC ACTCCAGCCT 1560
GGGCCATAGA GCGAGACTGC ATCTCAAAAA AAAAAAAAAG AAAAAAAAAA AACCAGAGGT 1620
|
